port-77
Small moleculeexperimental
Clinical trial activity
2 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Apr 8, 2024 (NCT06346509)
Timeline
Indications
Mechanism of action
- UnclearUnclear
Unclear unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06971900 | Phase 2 | Apr 4, 2025 | Celerion, Portal Therapeutics, Inc. |
| NCT06346509 | Phase 1 | Apr 8, 2024 | Portal Therapeutics, Inc. |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Portal Therapeutics, Inc. | For profit | 2 | 2 | 2 | 2024 |
| Celerion | For profit | 1 | 0 | 1 | 2025 |
2 organizations
Page 1 / 1